Argatroban Plus R-tPA for Acute Ischemic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

808

Participants

Timeline

Start Date

December 21, 2018

Primary Completion Date

January 30, 2022

Study Completion Date

January 30, 2022

Conditions
Stroke
Interventions
DRUG

rt-PA

Intravenous throbolysis with 0.9mg/kg rtPA

DRUG

Argatroban

100 ug/kg bolus over 3 to 5 minutes was administered intravenously, followed by a continuous Argatroban infusion of 1.0 ug/kg per minute for 48 hours adjusted to a target activated partial thromboplastin time of 1.75 X baseline (about 10%)

Trial Locations (1)

Unknown

General Hospital of ShenYang Military Region, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER

NCT03740958 - Argatroban Plus R-tPA for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter